Bayer including pneumonia and tuberculosis. Bayer scientists were not the first to make heroin, but the company led the way in commercializing it. "Heroin" was a Bayer trademark until after World War I. In 1903 Bayer licensed the patent for the hypnotic drug diethylbarbituric acid from its inventors Emil Fischer and Joseph von Mering. It was marketed under the trade name Veronal as a sleep aid beginning in 1904. Systematic investigations of the effect of structural changes on potency and duration of action at Bayer led to the discovery of phenobarbital in 1911 and the discovery of its potent anti-epileptic activity
Trade name Trade name A trade name, trading name, or business name is a pseudonym frequently used by companies to operate under a name different from their registered, legal name. The term for this type of alternative name is a "fictitious" business name. Registering the fictitious name with the relevant government body is often required. In a number of countries, the phrase "trading as" (abbreviated to t/a) is used to designate a trade name. In the United States, the phrase "doing business as" (abbreviated to DBA, dba, d.b.a. or d/b/a) is used, among others, such as assumed business name. In Canada, "operating